The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
Open accessThe DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
Abstract
Insulin resistance arises when the nutrient storage pathways evolved to maximize efficient energy utilization are exposed to chronic energy surplus. Ectopic lipid accumulation in liver and skeletal muscle triggers pathways that impair insulin signaling, leading to reduced muscle glucose uptake and decreased hepatic glycogen synthesis. Muscle insulin resistance, due to ectopic lipid, precedes liver insulin resistance and diverts ingested glucose to the liver, resulting in increased hepatic de novo lipogenesis and hyperlipidemia. Subsequent macrophage infiltration into white adipose tissue (WAT) leads to increased lipolysis, which further increases hepatic triglyceride synthesis and hyperlipidemia due to increased fatty acid esterification. Macrophage-induced WAT lipolysis also stimulates hepatic gluconeogenesis, promoting fasting and postprandial hyperglycemia through increased fatty acid delivery to the liver, which results in increased hepatic acetyl-CoA content, a potent activator of pyruvate carboxylase, and increased glycerol conversion to glucose. These substrate-regulated processes are mostly independent of insulin signaling in the liver but are dependent on insulin signaling in WAT, which becomes defective with inflammation. Therapies that decrease ectopic lipid storage and diminish macrophage-induced WAT lipolysis will reverse the root causes of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Supporting this perspective, monosaccharides have been shown to activate ChREBP and other key lipogenic transcription factors—including SREBP1c, LXR, and PPARγ—via insulin-independent mechanisms [34,70,83,86,99].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [99]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In both animal models and human patients, obesity‐induced hyperlipidaemia and lipotoxicity‐induced inflammation is thought to be one of the drivers for SO.[ 63 ]”
From Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review (2022) · cites this paper as [63]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In lipid infusion experiments, DAG content in the muscle increases, and consequently PKCθ is activated, resulting in limited phosphorylation of IRS-1 and glucose uptake through GLUT4 [9].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [9]
In the citing paper
“Insulin resistance is the core mechanism of sarcopenic obesity and is also associated with variable cardiometabolic diseases such as cardiovascular disease, type 2 diabetes mellitus, and non-alcoholic fatty liver disease.”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“Activated adipose tissue macrophages (ATMs) are recruited via chemokine signaling (96, 97) and release cytokines that promote lipolysis.”
BackgroundThe metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760 · cited 1×
“Activated adipose tissue macrophages (ATMs) are recruited via chemokine signaling (96, 97) and release cytokines that promote lipolysis.”
BackgroundLippa, N. C., & Sanderson, S. C. (2013) · Human Heredity · doi:10.1159/000353712 · Cited by 6,078
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093 · cited 2×
“Over a half century ago, Randle and colleagues concluded that muscle insulin resistance associated with obesity could be attributed to increased fatty acid oxidation that limits insulin-stimulated glucose utilization (43).”
BackgroundGenetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416 · cited 1×
“A common single nucleotide polymorphism (rs738409, I48M) in the lipid droplet protein patatin-like phospholipase domaincontaining protein 3 (PNPLA3, also called adiponutrin) has been associated with increased hepatic steatosis but not insulin resistance (74).”
BackgroundKim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Defining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833 · cited 1×
“Insulin activates the insulin receptor tyrosine kinase (IRTK), with subsequent activation of kinases including 3-phosphoinositide-dependent kinase-1 (PDK1) and mTORC2 (6), which converge on Akt phosphorylation (6–8).”
BackgroundAlessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,826
Research works printed but not linked: 3
- 10.1210/jcem.87.8.8761 · doi:10.1210/jcem.87.8.8761 · Paper page
- Kersten, 2014, Physiological regulation of lipoprotein lipase, Biochim Biophys Acta, 1841, 919, 10.1016/j.bbalip.2014.03.013 · DOI · Paper page
- 10.1172/JCI10294 · DOI · Paper page
Cited by
Items 801–900 of 998
Xie, X., Liao, J., Huang, C., Li, X., Cao, Q., Kong, L., Okamura, T., Hashimoto, Y., Obora, A., Kojima, T., et al. (2023) · International Journal of Medical Sciences · doi:10.7150/ijms.83371 · Cited by 8
Triglyceride Glucose Index and Prognosis of Patients with Subarachnoid Hemorrhage
Xie, Z., Wang, J., Zhu, S., Zhang, M., & Lv, X. (2024) · World Neurosurgery · doi:10.1016/j.wneu.2024.03.063 · Cited by 8
Ji, X., Yin, H., Gu, T., Xu, H., Fang, D., Wang, K., Sun, H., Tian, S., Wu, T., Nie, Y., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114465 · Cited by 8
Gao, Q., Jiang, Y., Song, Z., Ren, H., Kong, Y., Wang, C., Zheng, M., Shan, C., & Yang, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-67755-7 · Cited by 10
Early‐life exposure to alcohol and the risk of alcohol‐induced liver disease in adulthood
Asiedu, B., Nyakudya, T. T., Lembede, B. W., & Chivandi, E. (2021) · Birth Defects Research · doi:10.1002/bdr2.1881 · Cited by 12
“Insulin resistance results from a decrease in insulin capacity to suppress hepatic glucose production yet continue to stimulate lipogenesis, causing hyperglycemia, hyperlipidemia, and hepatic steatosis (Samuel & Shulman, 2016).”
BackgroundDMRT2 Interacts With FXR and Improves Insulin Resistance in Adipocytes and a Mouse Model
Tao, J., Yu, X., Yuan, Y.-J., Shen, X., Liu, J., Gu, P.-P., Wang, Z., Ma, Y.-T., & Li, G. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.723623 · Cited by 9
“As a critical factor resulting in insulin resistance, obesity is often accompanied by adipocyte enlargement, macrophage infiltration, excessive secretion of triglycerides in adipose tissues, and many other alterations (28).”
BackgroundVillalva-Pérez, J. M., Ramírez‐Vargas, M. A., Serafín-Fabián, J. I., Ramírez, M., Moreno‐Godínez, M. E., Espinoza-Rojo, M., & Flores‐Alfaro, E. (2020) · Cytotechnology · doi:10.1007/s10616-020-00398-4 · Cited by 11
Insulin Resistance as a Risk Factor for Flavum Hypertrophy in Lumbar Spinal Stenosis
Sakai, Y., Wakao, N., Matsui, H., Osada, N., Watanabe, T., & Watanabe, K. (2024) · Spine Surgery and Related Research · doi:10.22603/ssrr.2024-0025 · Cited by 8
He, M., Zhang, Y., Zhai, Y., Li, Y., Yang, G., Yu, S., Xiao, H., & Song, Y. (2024) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgae035 · Cited by 9
Adipose Tissue Immunometabolism: Unveiling the Intersection of Metabolic and Immune Regulation
Medina-Urrutia, A. X., Torre-Villalvazo, I., & Juárez-Rojas, J. G. (2024) · Revista de investigaci�n Cl�nica · doi:10.24875/ric.23000231 · Cited by 21
High sugar diet–induced fatty acid oxidation potentiates cytokine-dependent cardiac ECM remodeling
Gera, J., Kumar, D., Chauhan, G., Choudhary, A., Rani, L., Mandal, L., & Mandal, S. (2024) · The Journal of Cell Biology · doi:10.1083/jcb.202306087 · Cited by 8
“…cardiac efficiency (Lopaschuk et al., 2021; Mazumder et al., 2004; Randle et al., 1963), impairs insulin metabolic signaling (Atkinson et al., 2003; Samuel and Shulman, 2016), ele-vates the production of ROS (Tsushima et al., 2018), increases mitochondrial membrane uncoupling, promotes…”
Biochemical basis and therapeutic potential of mitochondrial uncoupling in cardiometabolic syndrome
dos Santos, B. G., Brisnovali, N. F., & Goedeke, L. (2024) · Biochemical Journal · doi:10.1042/bcj20240005 · Cited by 8
Field, J. T., Chapman, D. C., Hai, Y., Ghavami, S., West, A. R., Özerkliğ, B., Saleem, A., Kline, J., Mendelson, A. A., Kindrachuk, J., et al. (2025) · Autophagy · doi:10.1080/15548627.2025.2476872 · Cited by 11
“Previously, we demonstrated that BNIP3L is responsive to diacylglyceride accumulation, known to promote insulin resistance [32], to activate mitophagy and inhibit insulin signaling through a mechanism contingent on IRS1 phosphorylation [6,24].”
Liao, J. M., Lu, D., Xie, H., & Wang, M. (2025) · PLoS ONE · doi:10.1371/journal.pone.0308994 · Cited by 7
Johnson, R., Shabalala, S. C., Mabasa, L., Kotzé-Hörstmann, L. M., Sangweni, N. F., Ramharack, P., Sharma, J. R., Pheiffer, C., Arowolo, A., & Gijsen, H. S. (2025) · Scientific Reports · doi:10.1038/s41598-025-02001-2 · Cited by 9
“Although insulin receptor signalling has been shown to upregulate SREBP1 56 , we observed mildly increased SREBP1 expression amidst the downregulation of insulin receptor signalling.”
Wang, H., Tian, J., & Mi, J. (2025) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2025.100415 · Cited by 12
Craciun, C. I., Măgureanu, D. C., Bocșan, I. C., Craciun, A. E., Buzoianu, A. D., & Maria Adriana, N. E. A. G. (2026) · Diabetology · doi:10.3390/diabetology7030059 · Cited by 10
AT1 receptor downregulation: A mechanism for improving glucose homeostasis
Lopez, D. L., Casillas, O. E., Jaramillo, H. J., Romero‐García, T., & Vázquez-Jiménez, J. G. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i3.170 · Cited by 8
Increased insulin resistance with reduced beta cell function in recovered COVID-19 Ghanaians
Adatsi, R. K., Bockarie, A. S., Derkyi‐Kwarteng, L., Pappoe, F., Nsiah, P., Dankwa, K. N. A., & Acquah, S. (2023) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2023.100150 · Cited by 7
Lin, Y., Wang, Y., Zhang, Q., Gao, R., Chang, F., Li, B., Huang, K., Cheng, N., & He, X. (2024) · Biomolecules · doi:10.3390/biom14091193 · Cited by 9
“Inhibition Our findings indicated that treatment with 300 µmol/L PA led to the lowest glucose consumption (Figure 6B) and inhibited the expression of PI3K and AKT (Figure 6C). of glycogen synthesis is another distinctive feature of IR [41].”
BackgroundMutlu, B., Sharabi, K., Sohn, J. H., Yuan, B., Latorre‐Muro, P., Qin, X., Yook, J.-S., Lin, H., Yu, D., Camporez, J. P., et al. (2024) · Cell chemical biology · doi:10.1016/j.chembiol.2024.09.001 · Cited by 9
Self-citationToft‐Hansen, H., Aniol-Nielsen, C., Elias, D., Dahlbäck, M., Rossing, P. R., Sivalingam, S., Hagopian, W., Schneider, D., Nielsen, C. H., & Solberg, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041730 · Cited by 8
“This can jeopardize blood sugar management, potentially affecting lipid and protein metabolism and causing long-term complications such as cardiovascular diseases, nephropathy, retinopathy, and neuropathy [3,4].”
Effects of High-Fat Feeding on Skeletal Muscle Gene Expression in Diabetic Goto-Kakizaki Rats
Nie, J., DuBois, D. C., Xue, B., Jusko, W. J., & Almon, R. R. (2017) · Gene Regulation and Systems Biology · doi:10.1177/1177625017710009 · Cited by 8
“Here, with data sets from animals on HFD, 3 comparisons were made as follows: (1) GK-HFD vs GK-ND, (2) WKY-HFD vs WKY-ND, and (3) GK-HFD vs WKY-HFD.”
MethodKoike, S., Hsu, M.-F., Bettaieb, A., Chu, B., Matsumoto, N., Morisseau, C. H. P., Havel, P. J., Huising, M. O., Hammock, B. D., & Haj, F. G. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.05.029 · Cited by 8
Dietary patterns and type 2 diabetes—relationship to metabolic syndrome and inflammation
Bohn, T., Samouda, H., & Alkerwi, A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822130-3.00014-4 · Cited by 9
Wang, C., & Tsai, H. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i6.454 · Cited by 7
Insulin resistance by the triglyceride-glucose index in a rural Brazilian population
Ferreira, J. R. S., Zandonade, E., Bezerra, O. M. D. P. A., & Salaroli, L. B. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000509 · Cited by 7
“That is, the use of insulin-stimulated glucose is limited by the increased oxidation of fatty acids (24).”
BackgroundResearch progress on ncRNAs regulation of mitochondrial dynamics in diabetes
Wu, Y., Lan, H., Zhang, D., Hu, Z., Zhang, J., Li, Z., Xia, P., Tang, X., Cai, X., & Yu, P. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30878 · Cited by 7
“The gluconeogenesis (promoting the assembly of glucose with other sugars, glycerol, and amino acids) in the liver is activated by IR, yielding more energy available for glucose production (Samuel & Shulman, 2016).”
BackgroundGuo, H., Duolikun, D., & Yao, Q. (2023) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-023-01190-8 · Cited by 9
Sun, J., Jin, X., Zhang, X., & Zhang, B. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110741 · Cited by 8
Pathogenesis of Type 2 Diabetes Mellitus
Kalin, M. F., Goncalves, M., & Fonseca, V. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-20797-1_13-1 · Cited by 10
Atorvastatin and insulin equally mitigate brain pathology in diabetic rats
Pratchayasakul, W., Thongnak, L., Chattipakorn, K., Lungaphin, A., Pongchaidecha, A., Satjaritanun, P., Jaiwongkam, T., Kerdphoo, S., & Chattipakorn, S. C. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.01.021 · Cited by 8
Grundy, S. M. (2018) · Endocrinology · doi:10.1007/978-3-319-44433-8_3 · Cited by 7
Pathogenesis of Type 2 Diabetes Mellitus
Kalin, M. F., Goncalves, M., John‐Kalarickal, J., & Fonseca, V. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-20797-1_13-2 · Cited by 11
Genetic depletion of adipose-derived Isthmin-1 causes hepatic steatosis
Reghupaty, S. C., Voilquin, L., Zhao, M., Narasimhan, R., Patel, A. N., Lone, J. B., Bielczyk-Maczyńska, E., Danneskiold‐Samsøe, N. B., Brown, T., Jiang, Z., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102172 · Cited by 6
Amanat, M., Chib, S., Singh, T. G., & Singh, R. (2025) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2025.2513517 · Cited by 10
“NAFLD starts with fat buildup in the liver due to a mismatch between fat storage and breakdown, heavily influenced by insulin resistance, which increases free fatty acids in the liver (Figure 10) (Samuel and Shulman 2016).”
Liu, D., Zhong, J., Xuan, W., Chen, W., Yuan, J., Zhang, X., & He, L. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-01974-5 · Cited by 7
“Hypertriglyceridemia may also increase the delivery of free fatty acids to the liver, resulting in increased glucose production from the liver and disruption of glucose metabolism in target organs [23].”
Aging-Related Obesity: Unveiling Mitochondrial and Metabolic Dysfunction
Qi, T., Zhang, K., Zhang, J., Ma, Y., Hou, N., Sun, X., Han, F., Sheng, S., & Kan, C. (2025) · Current Nutrition Reports · doi:10.1007/s13668-025-00685-6 · Cited by 9
“This represents a key gap in mechanistic understanding [80]. effectively and is often accompanied by chronic inflamma - tion, further hindering insulin signaling [89, 90].”
Kim, J. (2025) · Diseases · doi:10.3390/diseases13080239 · Cited by 10
“The simultaneous elevation of TG and FBG, coupled with central obesity, is suggestive of potential mechanisms such as increased hepatic lipogenesis, reduced insulin sensitivity in adipose tissue, and impaired glucose uptake in peripheral tissues [44].”
Zheng, J., Gaspar, R. C., Sakuma, I., Hubbard, B. T., Zhang, D., Nasiri, A. R., Kahn, M., Perelis, M., Samuel, V. T., Petersen, K. F., et al. (2025) · Diabetologia · doi:10.1007/s00125-025-06539-8 · Cited by 7
“Given the critical role for the PM sn -1,2-DAGs–nPKC pathway in mediating lipid-induced insulin resistance, we measured PM sn -1,2-DAGs in liver and skeletal muscle, as well as the translocation of PKCɛ in the liver and both PKCθ and PKCɛ in skeletal muscle [25, 26].”
Self-citationDu, J., Man, Z., Bai, X., Luo, D., Guo, Q., Wang, Y., Yan, Y., Su, X., & Zheng, W. (2026) · Cardiovascular Diabetology · doi:10.1186/s12933-026-03151-x · Cited by 6
“In adipose tissue, it increases lipolysis, elevating circulating free fatty acids (FFAs) [45].”
A shared stress-inflammation signalling architecture underlying chronic disease and multimorbidity
Kopp, W. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1813984 · Cited by 8
Dutta, G., Mishra, P., Mishra, S. P., & Badhai, J. (2026) · Onco · doi:10.3390/onco6030031 · Cited by 7
“This is accompanied by increased release of inflammatory mediators and lipid metabolites into the circulation, thereby worsening metabolic dysfunction in peripheral tissues [34–36].”
Bukhari, S. A., Yasmin, A., Rasul, A., Zahoor, M. A., Mustafa, G., Farraj, D. A. A., Darwish, N., Aleya, L., & Rehman, A. U. (2022) · Dose-Response · doi:10.1177/15593258211069707 · Cited by 6
“The development of T2D is proposed due to various physiological mechanisms, including dysfunction of mitochondria and β-cells, oxidative stress, glycol-lipotoxicity, insulin resistance, and inflammation.(4) Adipose tissues (ATs) play critical roles in the homeostasis of glucose and lipids.”
BackgroundAcosta‐Manzano, P., Acosta, F. M., Flor‐Alemany, M., Gavilán‐Carrera, B., Delgado‐Fernández, M., Baena‐García, L., Segura‐Jiménez, V., & Aparicio, V. A. (2022) · International Journal of Sport Nutrition and Exercise Metabolism · doi:10.1123/ijsnem.2021-0274 · Cited by 7
Ramzan, F., Jayaprakash, R., Pook, C. J., Foster, M. J., Miles-Chan, J. L., & Mithen, R. F. (2022) · Nutrients · doi:10.3390/nu14081638 · Cited by 8
“Additionally, in the TOAST study, a lower increase in postprandial plasma triglycerides was observed in participants consuming 4 g/250 mL kawakawa tea prior to a high-glycemic meal compared to water control Postprandial glucose and insulin dysregulation are independent risk factors for obesity and related cardio-metab…”
BackgroundSkeletal muscle overexpression of sAnk1.5 in transgenic mice does not predispose to type 2 diabetes
Pierantozzi, E., Raucci, L., Buonocore, S., Rubino, E. M., Ding, Q., Laurino, A., Fiore, F., Soldaini, M., Chen, J., Rossi, D., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-35393-0 · Cited by 6
Omar, A. K., Puma, L. C. L., Whitcomb, L. A., Risk, B. D., Witt, A. C., Bruemmer, J. E., Winger, Q. A., Bouma, G. J., & Chicco, A. J. (2023) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00059.2023 · Cited by 7
Role of a Whole Plant Foods Diet in Breast Cancer Prevention and Survival
Jiménez, M. D. C. F.-F. (2025) · Journal of the American Nutrition Association · doi:10.1080/27697061.2024.2442631 · Cited by 10
Lee, J. I., Lee, H. M., Park, J., & Lee, Y. G. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70010 · Cited by 6
“Although the mechanisms underlying IR have yet to be fully understood, studies indicate that it precedes nonphysio-logical increases in blood glucose levels and promotes excessive gluconeogenesis, thereby triggering hyperglycemia, an initial symptom of metabolic diseases [3].”
Anti-diabetic Nano-formulation from Herbal Source
Das, A., Saikia, R., Pathak, K., Gogoi, U., & Pathak, M. P. (2020) · Springer eBooks · doi:10.1007/978-981-15-6255-6_4 · Cited by 6
Vitamin K2 as a New Modulator of the Ceramide De Novo Synthesis Pathway
Kołakowski, A., Kurzyna, P. F., Żywno, H., Bzdęga, W., Harasim‐Symbor, E., Chabowski, A., & Konstantynowicz-Nowicka, K. (2021) · Molecules · doi:10.3390/molecules26113377 · Cited by 6
“Insulin resistance c ompanies many metabolic disorders, such as type 2 diabetes or metabolic syndrome [10].”
BackgroundA New Oral Model to Assess Postprandial Lactate Production Rate
Bonet, J., Galuppo, B., Santoro, N., & Man, C. D. (2021) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2021.3124143 · Cited by 6
Bajahzer, M., Bruun, J. M., Rosqvist, F., Marklund, M., Richelsen, B., & Risérus, U. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.936828 · Cited by 7
“When glycogen depots in the liver and muscles are saturated, glycogenesis is inhibited, whereas DNL is stimulated in the presence of insulin to utilize plasma glucose to synthesize palmitate (16:0), the primary DNL product (4).”
BackgroundAlghanem, L., Zhang, X., Jaiswal, R., Seyoum, B., Mallisho, A., Msallaty, Z., & Yi, Z. (2022) · ACS Omega · doi:10.1021/acsomega.2c04473 · Cited by 7
Tejera‐Muñoz, A., Guerra-Menéndez, L., Amor, S., González‐Hedström, D., García-Villalón, Á. L., & Granado, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914443 · Cited by 6
“…of insulin resistance [6], a condition associated with a decreased activation of the PI3K-Akt pathway in insulin-dependent tissues such as the liver skeletal muscle and adipose tissue, which results in an impaired uptake and storage of glucose, promoting hyperglycemia in the long term [13].”
BackgroundPredictive value of first-trimester GPR120 levels in gestational diabetes mellitus
He, Q., Lin, M., Wu, Z., & Yu, R. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1220472 · Cited by 7
Terzo, S., Calvi, P., Giardina, M., Gallizzi, G., Carlo, M. D., Nuzzo, D., Picone, P., Puleio, R., Mulè, F., Scoglio, S., et al. (2023) · Cells · doi:10.3390/cells12232706 · Cited by 7
“Although human studies are necessary to confirm the effects of AFA extract, the present study offers a new potential and natural approach to the treatment of obesity-related dysfunctions.”
Backgroundvan Vuren, E. J., Malan, L., von Känel, R., Magnusson, M., Lammertyn, L., & Malan, N. T. (2018) · Diabetes and Vascular Disease Research · doi:10.1177/1479164118816221 · Cited by 7
“Insulin is responsible for the regulation of metabolism as it promotes glycogen synthesis and glucose uptake into the cells while inhibiting glucose release into the circulation.(36) With IR, the tissues thus show reduced sensitivity to insulin-mediated biological activity.”
BackgroundInfluentialLipoprotein insulin resistance score in nondiabetic patients with obesity after bariatric surgery
Zhang, R., Lin, B., Parikh, M., Fisher, E. A. A., Berger, J. S., Alemán, J. O., & Heffron, S. P. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2020.05.008 · Cited by 6
“Preclinical insulin resistance often precedes the diagnosis of Type II diabetes (T2D) by many years [1].”
Genetic determinants of obesity heterogeneity in type II diabetes
Khorami, S. A. H., Mutalib, M. S. A., Shiraz, M. F., Abdullah, J. A., Rejali, Z., Ali, R. M., & Khaza’ai, H. (2020) · Nutrition & Metabolism · doi:10.1186/s12986-020-00476-6 · Cited by 9
“Mice lacking PKC were protected from diet-induced insulin resistance, even with increased hepatic lipid content [50].”
BackgroundCalcium-dependent insulin resistance in hepatocytes: mathematical model
Dokukina, I. V., Yamashev, M. V., Samarina, E. A., Tilinova, O. M., & Grachev, E. A. (2021) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2021.110684 · Cited by 6
Xenoulis, P. G., Heilmann, R. M., Stavroulaki, E. M., Riggers, D. S., Gneipel, L. J., Suchodolski, J. S., & Steiner, J. M. (2022) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.16418 · Cited by 5
Imrie, H., Viswambharan, H., Haywood, N. J., Bridge, K., Yuldasheva, N. Y., Galloway, S. L., Simmons, K. J., Cubbon, R. M., Sukumar, P., Watt, N. T., et al. (2022) · Adipocyte · doi:10.1080/21623945.2022.2089394 · Cited by 6
“Interestingly, we found a depot-specific effect of cixutumumab on these genes, dysregulation of which are thought to contribute to the pathogenesis of the metabolic syndrome [11].”
BackgroundBariatric surgery normalizes diabetes risk index by one month post-operation
Sinatra, V. J., Lin, B., Parikh, M., Berger, J. S., Fisher, E. A. A., & Heffron, S. P. (2022) · Acta Diabetologica · doi:10.1007/s00592-022-02002-x · Cited by 6
Weight-gain independent effect of mirtazapine on fasting plasma lipids in healthy men
Lechner, K., Heel, S., Uhr, M., Dose, T., Holsboer, F., Lucae, S., Schaaf, L., Fulda, S., Kloiber, S. M., & Hennings, J. M. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02448-y · Cited by 8
“2016; Samuel and Shulman 2016).”
BackgroundJustesen, J. M., Galijatovic, E. A. A., Allin, K. H., Sandholt, C. H., Jørgensen, T., Linneberg, A. R., Jørgensen, M. E., Hansen, T. F., Pedersen, O. B., & Grarup, N. (2016) · Journal of Lipid Research · doi:10.1194/jlr.p068379 · Cited by 6
Wang, H., Ti, Y., Zhang, J., Peng, J., Zhou, H., Zhong, M., Xing, Y., Zhang, Y., Zhang, W., & Wang, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.16078 · Cited by 6
“As a consequence, excessive free fatty acids (FFAs) and unbalanced cluster of adipokines would be released into circulation.”
BackgroundSarcopenic Obesity: The Underlying Molecular Pathophysiology and Prospect Therapies
Meiliana, A., Dewi, N. M., Defi, I. R., Rosdianto, A. M., Qiantori, A. A., & Wijaya, A. (2024) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v16i4.3176 · Cited by 7
“Insulin resistance (IR) is a common mechanism linked to the diseases (25), and obesity, high calorie consumption, and poor levels of physical exercise are the main contributors (26).”
BackgroundKamal, S., Gou, Y., Tsuzuki, T., Fu, L., Yamada, T., Banno, R., & Koike, T. (2025) · Nutrients · doi:10.3390/nu17122050 · Cited by 6
“Moreover, while both HF and high-sugar diets promote visceral fat accumulation and obesity, they might induce insulin resistance via distinct mechanisms that extend beyond the effects of obesity alone [2].”
Amirkalali, B., Farahmand, M., Rashedi, M. H., Gholami, A., Sheikholmolooki, F., Sedighi, M., & Doustmohammadian, A. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1596300 · Cited by 6
“Additionally, high DII diets exacerbate insulin resistance, impairing lipid metabolism and driving hepatic fat accumulation (43).”
Opuntia ficus‐indica fruit consumption improves insulin resistance in mice with diet‐induced obesity
Terzo, S., Calvi, P., Restivo, I., Massaro, A., Tesoriere, L., Fernández‐Real, J. M., Giardina, M., Amato, A., Mulè, F., & Allegra, M. (2025) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.70038 · Cited by 7
“25 Oxidative stress is also crucial in the development of IR.”
Cao, C., Zhang, X., Han, Y. Y., Hu, H., & Wang, Y. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1516187 · Cited by 7
Li, Q., Feng, M., luo, Q., Ye, C. Y., Luo, Y. K., & Xu, Y. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1715364 · Cited by 5
“It in fl uences fatty acid absorption, short-chain fatty acid (SCFA) production, and bile acid metabolism (Le Roy et al., 2013; O ’ Connor et al., 2014; Samuel and Shulman, 2016).”
PANoptosis in diabetes: immunometabolic insights and treatments
Ma, L., Li, Z., Liu, Q., Wu, N., & Wang, Q. (2026) · APOPTOSIS · doi:10.1007/s10495-025-02208-8 · Cited by 5
“…expressed, the altered metabolic profile of macrophages membranes and decreasing glucose uptake, ultimately leading to systemic insulin resistance [123, 124]. β-cell failure is a common outcome in the progression of both T1DM and T2DM to advanced stages, although their immunometabolic driving…”
Li, X., Miao, X., Zhang, X., Tian, H., Wang, L. C., Liu, J., Zhang, J., Tan, R., & Huang, J. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c15040 · Cited by 5
Soura, M., Bakiri, A., Fragoulis, G., & Vassilakis, K. D. (2026) · Rheumatology International · doi:10.1007/s00296-026-06099-z · Cited by 5
“Despite that, the pro-lipogenic effect of insulin is preserved [ 16], which in the setting of compensatory hyperinsulinemia (due to GIH), increases de novo hepatic lipogenesis leading to steatosis and exacerbation of hepatic insulin resistance [ 17 , 18].”
Song, K., Yang, J., Lee, H. S., Oh, J. S., Kim, S., Lee, M., Suh, J., Kwon, A., Kim, H.-S., & Chae, H. W. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1166244 · Cited by 7
“Insulin resistance promotes hepatic de novo lipogenesis by activating sterol regulatory element–binding protein 1 and lipid accumulation by inactivating Forkhead box protein A2, a transcription factor that promotes fatty acid oxidation in the liver (28, 29).”
BackgroundManagement of diabetes mellitus using medicinal plants: A review
Sivakumar, A., Thanu, A. S., Vishnumukkala, T., Ganesh, K. A. B., Shetty, J. K., Jagadeesan, S., & Gopalakrishna, P. K. (2024) · Bioinformation · doi:10.6026/973206300200705 · Cited by 8
Diabetes and its Silent Partner: A Critical Review of Hyperinsulinemia and its Complications
Rangraze, I. R., El‐Tanani, M., Rabbani, S. A., Babiker, R. A., Matalka, I. I., & Rizzo, M. (2024) · Current Diabetes Reviews · doi:10.2174/0115733998311738240813110032 · Cited by 6
Treating metabolic dysfunction‐associated steatohepatitis: The fat‐trimming FGF21 approach
Li, X., Rao, Z., Hu, W., Lu, W., & Luo, Y. (2024) · Obesity Reviews · doi:10.1111/obr.13861 · Cited by 9
“89 These nuclear receptors, regulators, and responsive tissues have been known 95 However, any undue disruption of these regulatory pathways, inter-tissue crosstalk, and associated physiological processes can lead to an excessive accumulation of lipids characterized by increases in both the number…”
Effects of Quercetin Metabolites on Glucose‐Dependent Lipid Accumulation in 3T3‐L1 Adipocytes
Rendine, M., Venturi, S., Marino, M., Gardana, C., Möller, P., Martini, D., Riso, P., & Bo’, C. D. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70070 · Cited by 5
“In this context, normal glucose levels per se are associated with adequate insulin sensitivity and glucose metabolism [72–74].”
Koçyiğit, A., Kasap, B., Güler, E. M., Kaleli, H. N., Kesmen, M., Dikilitaş, M., & Karataş, E. (2019) · American Journal of Plant Sciences · doi:10.4236/ajps.2019.1011136 · Cited by 7
“An inhibition of tyrosine phosphorylation of insulin receptor substrate-1 (IRS-1) causes GLUT protein defects [5] [6].”
BackgroundJoseph, A., Parvathy, S., Varma, K. K., & Nandakumar, A. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00694-y · Cited by 6
Yudhani, R. D., Nugrahaningsih, D. A. A., Sholikhah, E. N., & Mustofa, M. (2021) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2021.6972 · Cited by 8
“This leads to the elevation of free fatty acids (FFA) and glycerol [10].”
BackgroundPoonprasartporn, A., & Chan, K. L. A. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114416 · Cited by 6
Advances in natural small molecules on pretranslational regulation of gluconeogenesis
Wu, X., & Chen, S. (2023) · Drug Development Research · doi:10.1002/ddr.22053 · Cited by 5
“…of peroxisome proliferator‐activated receptor‐γ coactivator 1α (PGC1‐1α) and FoxO1 and ultimately enhances PEPCK and G6Pase expression to enhance hepatic glucose production (Herzig et al., 2001; Koo et al., 2005; Samuel & Shulman, 2016). cAMP signaling can also be regulated by other factors.”
BackgroundMyosteatosis as a novel predictor of new‐onset diabetes mellitus after kidney transplantation
Wakamiya, T., Fujimoto, T., Endo, T., Nishioka, S., Yokoyama, N., Yamashita, S., Kikkawa, K., Hyodo, Y., Ishimura, T., Kohjimoto, Y., et al. (2023) · International Journal of Urology · doi:10.1111/iju.15304 · Cited by 6
Huang, X., Li, Z., Zhai, Z., Wang, Q., Wei, R., Mo, J., Huang, J., & Lu, W. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s447897 · Cited by 8
“…carcinoma (HCC), in which taking metformin, an insulin sensitizer, has a higher survival rate, lower rates of decompensation and HCC. 35 42 When hepatic steatosis modifies hepatocytokine secretion, it creates a complementary reciprocal condition that affects fatty acid metabolism and…”
BackgroundLee, M.-S., Noh, J.-W., & Lee, B.-C. (2024) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c23-00782 · Cited by 6
Juan, Z., Liu, X., Yue, J., Zhang, S., Li, L., & Wei, H. (2024) · Frontiers in Veterinary Science · doi:10.3389/fvets.2024.1429639 · Cited by 6
Hu, X., Li, Y., & Liu, X. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1544684 · Cited by 8
Wang, Y., Yu, Z.-F., Cheng, Y., Jia, B., Yu, G., Yin, X., & Wang, Y. (2017) · Medicine · doi:10.1097/md.0000000000007498 · Cited by 5
Chang-Rueda, C., Cañas-Urbina, A. O., Trujillo-Murillo, K. D. C., Espinoza-Ruiz, M., Feliciano-Díaz, J., Vázquez‐Moreno, M. A., & Lugo‐Trampe, Á. (2019) · Revista de la Facultad de Medicina · doi:10.15446/revfacmed.v67n4.67159 · Cited by 8
“(1) IR has been described as a major risk factor for type 2 diabetes mellitus and cardiovascular disease, conditions that have high morbidity and mortality rates, which explains its diagnostic importance.”
BackgroundWang, Z., Du, Z., Zhao, X., Guo, F., Wang, T., & Zhu, F. (2021) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029621996445 · Cited by 5
“Insulin resistance is one of the important pathophysiological mechanisms of IFG and Type 2 DM, and hypertriglyceridemia is one of the typical features of insulin resistance.(18) Studies on visceral obesity and insulin resistance have shown that TG is degraded by lipoprotein lipase to produce free fatty acids (FFA), wh…”
BackgroundTrang, N. T. T., Chiu, W., Feng, Y., Hsieh, S.-L., Tung, D. D., Chang, J., & Fong, T.-H. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/6007233 · Cited by 7
Siboto, A., Akinnuga, A. M., Ismail, M. B., Booysen, I. N., Sibiya, N. H., Ngubane, P. S., & Khathi, A. (2022) · Diabetology · doi:10.3390/diabetology3040040 · Cited by 6
“This could be due to unregulated gluconeogenesis and energy demand from insulin-resistant peripheral tissues [32,43].”
BackgroundButanda-Nuñez, A., Rodríguez‐Cortés, O., Ramos-Martínez, E., Cerbón, M. A., Escobedo, G., & Chavarría, A. (2024) · Adipocyte · doi:10.1080/21623945.2024.2374062 · Cited by 5
“Since insulin plays a crucial role in cell glucose entry, any disruption in insulin signal transduction interferes with glucose uptake by the cells, thus leading to hyperglycaemia [4].”
BackgroundInfluentialPioglitazone and cardiovascular risk reduction: time for a second look?
Perdigoto, A. L., Young, L. H., & Inzucchi, S. E. (2016) · Cardiovascular Endocrinology · doi:10.1097/xce.0000000000000110 · Cited by 5
Cheng, P.-C., Hsu, S.-R., Li, J.-C., Chen, C.-P., Chien, S.-C., Tu, S., Cheng, Y.-C., Liu, Y.-H., & Kuo, J.-F. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00234 · Cited by 6
“Once insulin resistance has developed, it affects heart function through the activation of protein kinase C (12).”
Background
Metadata
- Authors
- Samuel, V. T., & Shulman, G. I.
- Affiliations
- Veterans Health Administration (US)
- Howard Hughes Medical Institute (US)
- Venue
- Journal of Clinical Investigation
- Published
- 2016-01-04
- Volume
- 126
- Issue
- 1
- Pages
- 12-22
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC4701542
- OpenAlex
- W2230222215
- Cited by
- 1,484
- References
- 131
- Citations by year
- 2026: 192 · 2025: 162 · 2024: 152 · 2023: 150 · 2022: 150 · 2021: 143 · 2020: 134 · 2019: 136 · 2018: 114 · 2017: 99 · 2016: 51
- FWCI
- 18.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs (I01 BX000901)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-49230, R01DK049230, DK40936, DK 45735, R01DK040936, U24DK059635, R24DK085638, DK059635, DK-085638, P30DK045735)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- insulin resistance, type 2 diabetes, ectopic fat deposition, hepatic insulin signaling, skeletal muscle glucose uptake, hepatic gluconeogenesis, hepatic de novo lipogenesis, adipose tissue lipolysis, hepatic triglyceride synthesis, fatty acid esterification, hyperlipidemia, hyperglycemia, pyruvate carboxylase, acetyl-CoA, substrate flux, inflammation, energy surplus
- MeSH terms
- Adipose Tissue, Animals, Glucose, Humans, Insulin Resistance, Liver, Triglycerides, Signal Transduction, Muscle, Skeletal, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.